Atossa Therapeutics (ATOS) SEC Filings & 10K Form

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Free ATOS Stock Alerts

$1.42

+0.07 (+5.19%)

(As of 04/18/2024 ET)

Compare

Recent Atossa Therapeutics SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
03/18/2024 7:35 AM	Atossa Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/14/2024 7:30 PM	Atossa Therapeutics (Issuer) Cigler Tessa (Reporting)	Form 3 Initial statement of beneficial ownership of securities
03/14/2024 7:35 PM	Atossa Therapeutics (Issuer) Cigler Tessa (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
03/12/2024 7:30 AM	Atossa Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
11/15/2023 3:05 PM	Atossa Therapeutics (Issuer) Finn Jonathan (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
11/13/2023 8:10 AM	Atossa Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
11/13/2023 8:00 AM	Atossa Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
Get the Latest News and Ratings for ATOS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Atossa Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
11/09/2023 8:00 AM	Atossa Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
09/28/2023 3:28 PM	Atossa Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/14/2023 7:30 AM	Atossa Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/14/2023 7:35 AM	Atossa Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
07/13/2023 3:20 PM	Atossa Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/28/2023 8:01 AM	Atossa Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/23/2023 8:00 AM	Atossa Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/20/2023 7:15 PM	Atossa Therapeutics (Issuer) WEAVER GREGORY L (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/05/2023 8:00 AM	Atossa Therapeutics (Issuer) WEAVER GREGORY L (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/01/2023 8:15 AM	Atossa Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/15/2023 8:10 AM	Atossa Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/15/2023 8:15 AM	Atossa Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
05/05/2023 6:35 PM	Atossa Therapeutics (Issuer) Galli Stephen J (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/05/2023 6:35 PM	Atossa Therapeutics (Issuer) Chen Shu-Chih (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/05/2023 6:35 PM	Atossa Therapeutics (Issuer) Steinhart Richard I (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/05/2023 6:36 PM	Atossa Therapeutics (Issuer) Remmel H. Lawrence (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/05/2023 6:36 PM	Atossa Therapeutics (Issuer) WEAVER GREGORY L (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
04/26/2023 3:49 PM	Atossa Therapeutics (Filer)	Form DEFA14A

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies:

SEC Filings Tools:

This page (NASDAQ:ATOS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Atossa Therapeutics (ATOS) SEC Filings & 10K Form

Recent Atossa Therapeutics SEC Filings

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info